HARMONY BIOSCIENCES HOLDINGS (HRMY)
US4131971040 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 311.66M | 243.80M | 234.30M | 228.60M | 24.50M | |||
| Marketable Securities | 41.80M | 79.30M | N/A | N/A | N/A | |||
| Receivables | 74.14M | 54.70M | 34.80M | 22.20M | 4.30M | |||
| Inventories | 5.36M | 4.30M | 4.40M | 3.80M | 1.10M | |||
| Other Current Assets | 18.11M | 18.10M | 10.80M | 8.30M | 1.70M | |||
| Total Current Assets | 451.07M | 400.30M | 284.40M | 262.90M | 31.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.71M | 2.90M | 800.00K | 900.00K | 1.30M | |||
| Investments And Advances | 72.17M | 22.60M | N/A | N/A | N/A | |||
| Intangibles | 137.11M | 161.00M | 143.90M | 162.30M | 72.20M | |||
| Other Non-Current Assets | 148.39M | 87.20M | 4.30M | 900.00K | 1.70M | |||
| Total Non-Current Assets | 360.38M | 273.60M | 149.00M | 164.20M | 75.20M | |||
| TOTAL ASSETS | 811.45M | 673.90M | 433.40M | 427.10M | 106.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 15.00M | 2.00M | 2.00M | N/A | N/A | |||
| Accrued Expenses | 124.68M | 73.10M | 49.40M | 131.70M | 13.40M | |||
| Accounts Payable | 17.73M | 3.80M | 1.00M | 2.60M | 6.40M | |||
| Other Current Liabilities | 6.37M | 0.00 | 1.40M | 300.00K | 100.00K | |||
| Total Current Liabilities | 163.78M | 78.90M | 53.80M | 134.50M | 19.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 178.57M | 189.60M | 190.00M | 194.30M | 97.90M | |||
| Other Non-Current Liabilities | 2.11M | 2.50M | 3.20M | 1.10M | 500.00K | |||
| Total Non-Current Liabilities | 180.68M | 192.10M | 193.10M | 195.40M | 98.40M | |||
| TOTAL LIABILITIES | 344.46M | 271.00M | 246.90M | 329.90M | 118.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -143.28M | -272.10M | -453.60M | -488.20M | -422.90M | |||
| Additional Paid In Capital | 610.27M | 675.10M | 640.10M | 585.40M | N/A | |||
| Common Shares | 1.00K | 0.00 | 0.00 | 0.00 | 411.30M | |||
| Other Shareholders' Equity | 2.00K | -200.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 56.77M | 59.60M | 58.80M | 56.90M | 64.00M | |||
| Tangible Book Value per Share | 5.81 | 4.06 | 0.72 | -1.14 | -7.74 | |||
| Total Shareholders' Equity | 466.99M | 402.80M | 186.50M | 97.20M | -11.60M | |||
| TOTAL LIABILITIES AND EQUITY | 811.45M | 673.90M | 433.40M | 427.10M | 106.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.38 | 0.47 | 1.02 | 2.00 | -8.44 | |||
| Current Ratio | 2.75 | 5.07 | 5.29 | 1.95 | 1.58 | |||
| Return On Assets (ROA) | 15.88% | 26.93% | 7.98% | -14.94% | -175.45% | |||
| Return On Equity (ROE) | 27.59% | 45.06% | 18.55% | -65.64% | N/A | |||
| Return On Invested Capital (ROIC) | 22.03% | 15.01% | 17.13% | 4.29% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 48.50% | 32.85% | 44.75% | 19.62% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 90.83% | 80.54% | 4644.46% | N/A | N/A | |||
All data in USD